Molecular prognostic tumor profiling of type 1 and type 2 papillary renal cell carcinoma: Relevance to the development of tumor-specific targeted therapies

被引：0
|
作者：
Klatte, Tobias
Said, Jonathan W.
Seligson, David
LaRochelle, Jeffrey
Shuch, Brian
Kabbinavar, Fairooz F.
Zisman, Amnon
Pantuck, Allan J.
Belldegrun, Arie S.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60613-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [21] Tumor-specific Cytotoxicity and Type of Cell Death Induced by Benzaldehyde
    Ariyoshi-Kishino, Kaori
    Hashimoto, Ken
    Amano, Osamu
    Saitoh, Jun
    Kochi, Mutsuyuki
    Sakagami, Hiroshi
    ANTICANCER RESEARCH, 2010, 30 (12) : 5069 - 5076
  • [22] TUMOR-SPECIFIC MONOCLONAL-ANTIBODIES FOR RENAL-CELL CARCINOMA
    SCHARFE, T
    BECHT, E
    KALTWASSER, R
    THUROFF, JW
    JACOBI, GH
    HOHENFELLNER, R
    EUROPEAN UROLOGY, 1985, 11 (02) : 117 - &
  • [23] Tumor-specific cytotoxicity and type of cell death induced by benzocycloheptoxazines in human tumor cell lines
    Murayama, Hiromi
    Miyahara, Kaori
    Wakabayashi, Hidetsugu
    Kurihara, Teruo
    Hashimoto, Ken
    Amano, Osamu
    Kikuchi, Hirotaka
    Nakamura, Yukio
    Kanda, Yumiko
    Kunii, Shiro
    Motohashi, Noboru
    Sakagami, Hiroshi
    ANTICANCER RESEARCH, 2008, 28 (2A) : 1069 - 1078
  • [24] Collision kidney tumor with clear cell renal cell carcinoma and papillary type 1 renal cell carcinoma. A case report and review of the literature
    Lamprou, Stavros
    Glykas, Ioannis
    Fragkoulis, Charalampos
    Theodoropoulou, Georgia
    Koutsonikas, Georgios
    Papadopoulos, Georgios
    UROLOGIA JOURNAL, 2022, 89 (02) : 304 - 306
  • [25] Revisiting Prognostic Significance of Clinicopathological Features in Type 1 Papillary Renal Cell Carcinoma
    Jia, Liwei
    Murugan, Paari
    Al-Ahmadie, Hikmat
    Fine, Samson
    Gopalan, Anuradha
    Sirintrapun, S. Joseph
    Tickoo, Satish
    Chen, Ying-Bei
    Reuter, Victor
    LABORATORY INVESTIGATION, 2019, 99
  • [26] Revisiting Prognostic Significance of Clinicopathological Features in Type 1 Papillary Renal Cell Carcinoma
    Jia, Liwei
    Murugan, Paari
    Al-Ahmadie, Hikmat
    Fine, Samson
    Gopalan, Anuradha
    Sirintrapun, S. Joseph
    Tickoo, Satish
    Chen, Ying-Bei
    Reuter, Victor
    MODERN PATHOLOGY, 2019, 32
  • [27] Anti-Tumor activity of the multityrosine kinase inhibitor dasatinib in type 1 papillary renal cell carcinoma
    Pahwa, Roma
    Dubhashi, Janhavi
    Giri, Abhigya
    Thomas, Craig
    Ceribelli, Michele
    Jailwala, Parthav
    Lobanov, Alexei
    Singh, Anand
    Sourbier, Carole
    Ricketts, Christopher J.
    Vocke, Cathy D.
    Yang, Youfeng
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    CANCER RESEARCH, 2020, 80 (16)
  • [28] Re: The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2011, 186 (06): : 2208 - 2208
  • [29] Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT
    Young, Jonathan R.
    Coy, Heidi
    Douek, Michael
    Lo, Pechin
    Sayre, James
    Pantuck, Allan J.
    Raman, Steven S.
    ABDOMINAL RADIOLOGY, 2017, 42 (07) : 1911 - 1918
  • [30] EXTENT OF TUMOR NECROSIS IS AN INDEPENDENT PROGNOSTIC FACTOR FOR PAPILLARY RENAL CELL CARCINOMA
    Klatte, Tobias
    Remzi, Mesut
    Said, Jonathan W.
    Haitel, Andrea
    Kabbinavar, Fairooz
    Waldert, Matthias
    de Martino, Michela
    Marberger, Michael
    Belldegrun, Arie S.
    Pantuck, Allan J.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 352 - 352
12345